Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
Transfus Apher Sci
; 59(4): 102817, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-1235989
ABSTRACT
Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution and control of use of the product. This position paper is aimed to give recommendations on biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Immunization, Passive
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Transfus Apher Sci
Journal subject:
Hematology
Year:
2020
Document Type:
Article
Affiliation country:
J.transci.2020.102817
Similar
MEDLINE
...
LILACS
LIS